Annual Operating Expenses
$6.21 M
-$516.10 K-7.67%
August 31, 2024
Summary
- As of February 8, 2025, LEXX annual total operating expenses is $6.21 million, with the most recent change of -$516.10 thousand (-7.67%) on August 31, 2024.
- During the last 3 years, LEXX annual operating expenses has fallen by -$21.60 thousand (-0.35%).
- LEXX annual operating expenses is now -11.35% below its all-time high of $7.01 million, reached on August 31, 2018.
Performance
LEXX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.87 M
+$584.80 K+25.57%
November 30, 2024
Summary
- As of February 8, 2025, LEXX quarterly total operating expenses is $2.87 million, with the most recent change of +$584.80 thousand (+25.57%) on November 30, 2024.
- Over the past year, LEXX quarterly operating expenses has stayed the same.
- LEXX quarterly operating expenses is now -19.31% below its all-time high of $3.56 million, reached on May 31, 2018.
Performance
LEXX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LEXX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.7% | 0.0% |
| 3 y3 years | -0.3% | +61.6% |
| 5 y5 years | +45.9% | +61.6% |
LEXX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.7% | at low | at high | +253.3% |
| 5 y | 5-year | -8.7% | +45.9% | at high | +253.3% |
| alltime | all time | -11.3% | >+9999.0% | -19.3% | >+9999.0% |
Lexaria Bioscience Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $2.87 M(+25.6%) |
| Aug 2024 | $6.21 M(-7.7%) | $2.29 M(+25.2%) |
| May 2024 | - | $1.83 M(+124.7%) |
| Feb 2024 | - | $813.00 K(-36.8%) |
| Nov 2023 | - | $1.29 M(+12.3%) |
| Aug 2023 | $6.73 M(-1.1%) | $1.14 M(-53.6%) |
| May 2023 | - | $2.47 M(+83.9%) |
| Feb 2023 | - | $1.34 M(-24.6%) |
| Nov 2022 | - | $1.78 M(+117.2%) |
| Aug 2022 | $6.80 M(+9.1%) | $818.40 K(-67.3%) |
| May 2022 | - | $2.50 M(+69.7%) |
| Feb 2022 | - | $1.47 M(-26.8%) |
| Nov 2021 | - | $2.01 M(+53.2%) |
| Aug 2021 | $6.23 M(+42.8%) | $1.31 M(-51.5%) |
| May 2021 | - | $2.71 M(+114.1%) |
| Feb 2021 | - | $1.27 M(+34.1%) |
| Nov 2020 | - | $944.30 K(-4.2%) |
| Aug 2020 | $4.36 M(+2.5%) | $986.00 K(-29.3%) |
| May 2020 | - | $1.39 M(+33.8%) |
| Feb 2020 | - | $1.04 M(+11.2%) |
| Nov 2019 | - | $937.00 K(-17.3%) |
| Aug 2019 | $4.26 M(-39.2%) | $1.13 M(-9.2%) |
| May 2019 | - | $1.25 M(+7.1%) |
| Feb 2019 | - | $1.17 M(+63.8%) |
| Nov 2018 | - | $711.80 K(-46.1%) |
| Aug 2018 | $7.01 M(+271.1%) | $1.32 M(-62.9%) |
| May 2018 | - | $3.56 M(+131.8%) |
| Feb 2018 | - | $1.54 M(+158.6%) |
| Nov 2017 | - | $593.70 K(-10.4%) |
| Aug 2017 | $1.89 M(+54.0%) | $662.50 K(+83.1%) |
| May 2017 | - | $361.80 K(-21.4%) |
| Feb 2017 | - | $460.30 K(+13.9%) |
| Nov 2016 | - | $404.00 K(+20.8%) |
| Aug 2016 | $1.23 M(-35.9%) | $334.50 K(+33.3%) |
| May 2016 | - | $251.00 K(+1.9%) |
| Feb 2016 | - | $246.40 K(-37.5%) |
| Nov 2015 | - | $394.10 K(-34.1%) |
| Aug 2015 | $1.91 M | $598.10 K(+20.1%) |
| May 2015 | - | $498.00 K(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $453.90 K(+25.0%) |
| Nov 2014 | - | $363.00 K(-37.4%) |
| Aug 2014 | $1.27 M(+236.0%) | - |
| Jul 2014 | - | $579.50 K(+19.2%) |
| Apr 2014 | - | $486.00 K(+314.0%) |
| Jan 2014 | - | $117.40 K(+64.9%) |
| Oct 2013 | $378.40 K(-34.7%) | $71.20 K(-28.5%) |
| Jul 2013 | - | $99.60 K(+15.8%) |
| Apr 2013 | - | $86.00 K(-29.2%) |
| Jan 2013 | - | $121.50 K(+22.0%) |
| Oct 2012 | $579.40 K(-20.1%) | $99.60 K(-32.8%) |
| Jul 2012 | - | $148.20 K(-8.6%) |
| Apr 2012 | - | $162.10 K(-4.4%) |
| Jan 2012 | - | $169.50 K(+194.3%) |
| Oct 2011 | $725.40 K(+53.0%) | $57.60 K(-84.4%) |
| Jul 2011 | - | $369.80 K(+197.3%) |
| Apr 2011 | - | $124.40 K(+0.1%) |
| Jan 2011 | - | $124.30 K(+6.0%) |
| Oct 2010 | $474.00 K(+1.5%) | $117.30 K(+128.7%) |
| Jul 2010 | - | $51.30 K(-29.4%) |
| Apr 2010 | - | $72.70 K(-68.8%) |
| Jan 2010 | - | $232.70 K(+127.2%) |
| Oct 2009 | $467.20 K(-2.8%) | $102.40 K(-42.3%) |
| Jul 2009 | - | $177.60 K(+46.8%) |
| Apr 2009 | - | $121.00 K(+82.8%) |
| Jan 2009 | - | $66.20 K(+145.2%) |
| Oct 2008 | $480.70 K(-59.2%) | $27.00 K(-78.1%) |
| Jul 2008 | - | $123.40 K(-7.8%) |
| Apr 2008 | - | $133.80 K(+1.5%) |
| Jan 2008 | - | $131.80 K(-58.1%) |
| Oct 2007 | $1.18 M(+750.8%) | $314.20 K(-37.5%) |
| Jul 2007 | - | $502.50 K(+54.5%) |
| Apr 2007 | - | $325.30 K(+687.7%) |
| Jan 2007 | - | $41.30 K(+19.0%) |
| Oct 2006 | $138.50 K(+294.6%) | $34.70 K(-33.8%) |
| Jul 2006 | - | $52.40 K(+75.8%) |
| Apr 2006 | - | $29.80 K(+3.1%) |
| Jan 2006 | - | $28.90 K |
| Oct 2005 | $35.10 K | - |
FAQ
- What is Lexaria Bioscience annual total operating expenses?
- What is the all time high annual operating expenses for Lexaria Bioscience?
- What is Lexaria Bioscience annual operating expenses year-on-year change?
- What is Lexaria Bioscience quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly operating expenses year-on-year change?
What is Lexaria Bioscience annual total operating expenses?
The current annual operating expenses of LEXX is $6.21 M
What is the all time high annual operating expenses for Lexaria Bioscience?
Lexaria Bioscience all-time high annual total operating expenses is $7.01 M
What is Lexaria Bioscience annual operating expenses year-on-year change?
Over the past year, LEXX annual total operating expenses has changed by -$516.10 K (-7.67%)
What is Lexaria Bioscience quarterly total operating expenses?
The current quarterly operating expenses of LEXX is $2.87 M
What is the all time high quarterly operating expenses for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly total operating expenses is $3.56 M
What is Lexaria Bioscience quarterly operating expenses year-on-year change?
Over the past year, LEXX quarterly total operating expenses has changed by $0.00 (0.00%)